Canandaigua National Corp’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Canandaigua National Corp’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-25,483	Closed	-$79K	–	296
2021 Q4	$79K	Buy	25,483 +11,466	+82%	+$38.6K	0.01%	282
2021 Q3	$51K	Buy	14,017 +100	+0.7%	+$377	0.01%	267
2021 Q2	$50K	Sell	13,917 -1,461	-10%	-$5.15K	0.01%	268
2021 Q1	$60K	Sell	15,378 -376	-2%	-$1.55K	0.01%	268
2020 Q4	$66K	Buy	15,754 +1,491	+10%	+$5.75K	0.01%	254
2020 Q3	$53K	Sell	14,263 -470	-3%	-$2K	0.01%	260
2020 Q2	$64K	Buy	+14,733	New	+$66.2K	0.01%	265

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Canandaigua National Corp's BDSI Position: Q1 2022 in Review

Canandaigua National Corp sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 25,483 shares — an estimated $79K sold.

Canandaigua National Corp first reported a position in BDSI in Q2 2020 and held it in 7 quarters. The position peaked at $79K in Q4 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Canandaigua National Corp reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Canandaigua National Corp sold 25,483 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $79K.
Canandaigua National Corp first reported a position in BioDelivery Sciences International, Inc. in Q2 2020 and held it in 7 quarters.
Canandaigua National Corp's BioDelivery Sciences International, Inc. position peaked at $79K in Q4 2021.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Canandaigua National Corp's 13F filing for Q1 2022, filed 9 May 2022.